Global Health Product for Immune Market Growth 2022-2028
The global market for Health Product for Immune is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Health Product for Immune market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Health Product for Immune market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Health Product for Immune market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Health Product for Immune market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Health Product for Immune players cover Amway, Suntory, GNC, INFINITUS and Herbalife Nutrition, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Health Product for Immune market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Health Product for Immune market, with both quantitative and qualitative data, to help readers understand how the Health Product for Immune market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Health Product for Immune market and forecasts the market size by Form (Capsule/Pills, Powder and Liquid), by End Users (Children/Teenagers, Men, Adults and The Elderly), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by form
Capsule/Pills
Powder
Liquid
Segmentation by end users
Children/Teenagers
Men
Adults
The Elderly
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestlé SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
Nature's
Real Nutriceutical
Chapter Introduction
Chapter 1: Scope of Health Product for Immune, Research Methodology, etc.
Chapter 2: Executive Summary, global Health Product for Immune market size (sales and revenue) and CAGR, Health Product for Immune market size by region, by form, by end users, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Health Product for Immune sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Health Product for Immune sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by form, and form.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Health Product for Immune market size forecast by region, by country, by form, and end users.
Chapter 13: Comprehensive company profiles of the leading players, including Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, USANA Health Sciences, Inc., PERFECT, Nestlé SA and H&H Group, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Health Product for Immune Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Health Product for Immune by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Health Product for Immune by Country/Region, 2017, 2022 & 2028
2.2 Health Product for Immune Segment by Form
2.2.1 Capsule/Pills
2.2.2 Powder
2.2.3 Liquid
2.3 Health Product for Immune Sales by Form
2.3.1 Global Health Product for Immune Sales Market Share by Form (2017-2022)
2.3.2 Global Health Product for Immune Revenue and Market Share by Form (2017-2022)
2.3.3 Global Health Product for Immune Sale Price by Form (2017-2022)
2.4 Health Product for Immune Segment by End Users
2.4.1 Children/Teenagers
2.4.2 Men
2.4.3 Adults
2.4.4 The Elderly
2.5 Health Product for Immune Sales by End Users
2.5.1 Global Health Product for Immune Sale Market Share by End Users (2017-2022)
2.5.2 Global Health Product for Immune Revenue and Market Share by End Users (2017-2022)
2.5.3 Global Health Product for Immune Sale Price by End Users (2017-2022)
3 Global Health Product for Immune by Company
3.1 Global Health Product for Immune Breakdown Data by Company
3.1.1 Global Health Product for Immune Annual Sales by Company (2020-2022)
3.1.2 Global Health Product for Immune Sales Market Share by Company (2020-2022)
3.2 Global Health Product for Immune Annual Revenue by Company (2020-2022)
3.2.1 Global Health Product for Immune Revenue by Company (2020-2022)
3.2.2 Global Health Product for Immune Revenue Market Share by Company (2020-2022)
3.3 Global Health Product for Immune Sale Price by Company
3.4 Key Manufacturers Health Product for Immune Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Health Product for Immune Product Location Distribution
3.4.2 Players Health Product for Immune Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Health Product for Immune by Geographic Region
4.1 World Historic Health Product for Immune Market Size by Geographic Region (2017-2022)
4.1.1 Global Health Product for Immune Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Health Product for Immune Annual Revenue by Geographic Region
4.2 World Historic Health Product for Immune Market Size by Country/Region (2017-2022)
4.2.1 Global Health Product for Immune Annual Sales by Country/Region (2017-2022)
4.2.2 Global Health Product for Immune Annual Revenue by Country/Region
4.3 Americas Health Product for Immune Sales Growth
4.4 APAC Health Product for Immune Sales Growth
4.5 Europe Health Product for Immune Sales Growth
4.6 Middle East & Africa Health Product for Immune Sales Growth
5 Americas
5.1 Americas Health Product for Immune Sales by Country
5.1.1 Americas Health Product for Immune Sales by Country (2017-2022)
5.1.2 Americas Health Product for Immune Revenue by Country (2017-2022)
5.2 Americas Health Product for Immune Sales by Form
5.3 Americas Health Product for Immune Sales by End Users
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Health Product for Immune Sales by Region
6.1.1 APAC Health Product for Immune Sales by Region (2017-2022)
6.1.2 APAC Health Product for Immune Revenue by Region (2017-2022)
6.2 APAC Health Product for Immune Sales by Form
6.3 APAC Health Product for Immune Sales by End Users
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Health Product for Immune by Country
7.1.1 Europe Health Product for Immune Sales by Country (2017-2022)
7.1.2 Europe Health Product for Immune Revenue by Country (2017-2022)
7.2 Europe Health Product for Immune Sales by Form
7.3 Europe Health Product for Immune Sales by End Users
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Health Product for Immune by Country
8.1.1 Middle East & Africa Health Product for Immune Sales by Country (2017-2022)
8.1.2 Middle East & Africa Health Product for Immune Revenue by Country (2017-2022)
8.2 Middle East & Africa Health Product for Immune Sales by Form
8.3 Middle East & Africa Health Product for Immune Sales by End Users
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Health Product for Immune
10.3 Manufacturing Process Analysis of Health Product for Immune
10.4 Industry Chain Structure of Health Product for Immune
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Health Product for Immune Distributors
11.3 Health Product for Immune Customer
12 World Forecast Review for Health Product for Immune by Geographic Region
12.1 Global Health Product for Immune Market Size Forecast by Region
12.1.1 Global Health Product for Immune Forecast by Region (2023-2028)
12.1.2 Global Health Product for Immune Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Health Product for Immune Forecast by Form
12.7 Global Health Product for Immune Forecast by End Users
13 Key Players Analysis
13.1 Amway
13.1.1 Amway Company Information
13.1.2 Amway Health Product for Immune Product Offered
13.1.3 Amway Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amway Main Business Overview
13.1.5 Amway Latest Developments
13.2 Suntory
13.2.1 Suntory Company Information
13.2.2 Suntory Health Product for Immune Product Offered
13.2.3 Suntory Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Suntory Main Business Overview
13.2.5 Suntory Latest Developments
13.3 GNC
13.3.1 GNC Company Information
13.3.2 GNC Health Product for Immune Product Offered
13.3.3 GNC Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GNC Main Business Overview
13.3.5 GNC Latest Developments
13.4 INFINITUS
13.4.1 INFINITUS Company Information
13.4.2 INFINITUS Health Product for Immune Product Offered
13.4.3 INFINITUS Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 INFINITUS Main Business Overview
13.4.5 INFINITUS Latest Developments
13.5 Herbalife Nutrition
13.5.1 Herbalife Nutrition Company Information
13.5.2 Herbalife Nutrition Health Product for Immune Product Offered
13.5.3 Herbalife Nutrition Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Herbalife Nutrition Main Business Overview
13.5.5 Herbalife Nutrition Latest Developments
13.6 USANA Health Sciences, Inc.
13.6.1 USANA Health Sciences, Inc. Company Information
13.6.2 USANA Health Sciences, Inc. Health Product for Immune Product Offered
13.6.3 USANA Health Sciences, Inc. Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 USANA Health Sciences, Inc. Main Business Overview
13.6.5 USANA Health Sciences, Inc. Latest Developments
13.7 PERFECT
13.7.1 PERFECT Company Information
13.7.2 PERFECT Health Product for Immune Product Offered
13.7.3 PERFECT Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PERFECT Main Business Overview
13.7.5 PERFECT Latest Developments
13.8 Nestlé SA
13.8.1 Nestlé SA Company Information
13.8.2 Nestlé SA Health Product for Immune Product Offered
13.8.3 Nestlé SA Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Nestlé SA Main Business Overview
13.8.5 Nestlé SA Latest Developments
13.9 H&H Group
13.9.1 H&H Group Company Information
13.9.2 H&H Group Health Product for Immune Product Offered
13.9.3 H&H Group Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 H&H Group Main Business Overview
13.9.5 H&H Group Latest Developments
13.10 China New Era Group
13.10.1 China New Era Group Company Information
13.10.2 China New Era Group Health Product for Immune Product Offered
13.10.3 China New Era Group Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 China New Era Group Main Business Overview
13.10.5 China New Era Group Latest Developments
13.11 By-health
13.11.1 By-health Company Information
13.11.2 By-health Health Product for Immune Product Offered
13.11.3 By-health Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 By-health Main Business Overview
13.11.5 By-health Latest Developments
13.12 Black Mores
13.12.1 Black Mores Company Information
13.12.2 Black Mores Health Product for Immune Product Offered
13.12.3 Black Mores Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Black Mores Main Business Overview
13.12.5 Black Mores Latest Developments
13.13 Glanbia Plc
13.13.1 Glanbia Plc Company Information
13.13.2 Glanbia Plc Health Product for Immune Product Offered
13.13.3 Glanbia Plc Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Glanbia Plc Main Business Overview
13.13.5 Glanbia Plc Latest Developments
13.14 Nature's
13.14.1 Nature's Company Information
13.14.2 Nature's Health Product for Immune Product Offered
13.14.3 Nature's Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nature's Main Business Overview
13.14.5 Nature's Latest Developments
13.15 Real Nutriceutical
13.15.1 Real Nutriceutical Company Information
13.15.2 Real Nutriceutical Health Product for Immune Product Offered
13.15.3 Real Nutriceutical Health Product for Immune Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Real Nutriceutical Main Business Overview
13.15.5 Real Nutriceutical Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Health Product for Immune Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Health Product for Immune Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Capsule/Pills
Table 4. Major Players of Powder
Table 5. Major Players of Liquid
Table 6. Global Health Product for Immune Sales by Form (2017-2022) & (K Units)
Table 7. Global Health Product for Immune Sales Market Share by Form (2017-2022)
Table 8. Global Health Product for Immune Revenue by Form (2017-2022) & ($ million)
Table 9. Global Health Product for Immune Revenue Market Share by Form (2017-2022)
Table 10. Global Health Product for Immune Sale Price by Form (2017-2022) & (US$/Unit)
Table 11. Global Health Product for Immune Sales by End Users (2017-2022) & (K Units)
Table 12. Global Health Product for Immune Sales Market Share by End Users (2017-2022)
Table 13. Global Health Product for Immune Revenue by End Users (2017-2022)
Table 14. Global Health Product for Immune Revenue Market Share by End Users (2017-2022)
Table 15. Global Health Product for Immune Sale Price by End Users (2017-2022) & (US$/Unit)
Table 16. Global Health Product for Immune Sales by Company (2020-2022) & (K Units)
Table 17. Global Health Product for Immune Sales Market Share by Company (2020-2022)
Table 18. Global Health Product for Immune Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Health Product for Immune Revenue Market Share by Company (2020-2022)
Table 20. Global Health Product for Immune Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Health Product for Immune Producing Area Distribution and Sales Area
Table 22. Players Health Product for Immune Products Offered
Table 23. Health Product for Immune Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Health Product for Immune Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Health Product for Immune Sales Market Share Geographic Region (2017-2022)
Table 28. Global Health Product for Immune Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Health Product for Immune Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Health Product for Immune Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Health Product for Immune Sales Market Share by Country/Region (2017-2022)
Table 32. Global Health Product for Immune Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Health Product for Immune Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Health Product for Immune Sales by Country (2017-2022) & (K Units)
Table 35. Americas Health Product for Immune Sales Market Share by Country (2017-2022)
Table 36. Americas Health Product for Immune Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Health Product for Immune Revenue Market Share by Country (2017-2022)
Table 38. Americas Health Product for Immune Sales by Type (2017-2022) & (K Units)
Table 39. Americas Health Product for Immune Sales Market Share by Form (2017-2022)
Table 40. Americas Health Product for Immune Sales by End Users (2017-2022) & (K Units)
Table 41. Americas Health Product for Immune Sales Market Share by End Users (2017-2022)
Table 42. APAC Health Product for Immune Sales by Region (2017-2022) & (K Units)
Table 43. APAC Health Product for Immune Sales Market Share by Region (2017-2022)
Table 44. APAC Health Product for Immune Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Health Product for Immune Revenue Market Share by Region (2017-2022)
Table 46. APAC Health Product for Immune Sales by Form (2017-2022) & (K Units)
Table 47. APAC Health Product for Immune Sales Market Share by Form (2017-2022)
Table 48. APAC Health Product for Immune Sales by End Users (2017-2022) & (K Units)
Table 49. APAC Health Product for Immune Sales Market Share by End Users (2017-2022)
Table 50. Europe Health Product for Immune Sales by Country (2017-2022) & (K Units)
Table 51. Europe Health Product for Immune Sales Market Share by Country (2017-2022)
Table 52. Europe Health Product for Immune Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Health Product for Immune Revenue Market Share by Country (2017-2022)
Table 54. Europe Health Product for Immune Sales by Type (2017-2022) & (K Units)
Table 55. Europe Health Product for Immune Sales Market Share by Form (2017-2022)
Table 56. Europe Health Product for Immune Sales by End Users (2017-2022) & (K Units)
Table 57. Europe Health Product for Immune Sales Market Share by End Users (2017-2022)
Table 58. Middle East & Africa Health Product for Immune Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Health Product for Immune Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Health Product for Immune Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Health Product for Immune Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Health Product for Immune Sales by Form (2017-2022) & (K Units)
Table 63. Middle East & Africa Health Product for Immune Sales Market Share by Form (2017-2022)
Table 64. Middle East & Africa Health Product for Immune Sales by End Users (2017-2022) & (K Units)
Table 65. Middle East & Africa Health Product for Immune Sales Market Share by End Users (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Health Product for Immune
Table 67. Key Market Challenges & Risks of Health Product for Immune
Table 68. Key Industry Trends of Health Product for Immune
Table 69. Health Product for Immune Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Health Product for Immune Distributors List
Table 72. Health Product for Immune Customer List
Table 73. Global Health Product for Immune Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Health Product for Immune Sales Market Forecast by Region
Table 75. Global Health Product for Immune Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Health Product for Immune Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Health Product for Immune Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Health Product for Immune Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Health Product for Immune Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Health Product for Immune Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Health Product for Immune Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Health Product for Immune Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Health Product for Immune Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Health Product for Immune Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Health Product for Immune Sales Forecast by Form (2023-2028) & (K Units)
Table 86. Global Health Product for Immune Sales Market Share Forecast by Form (2023-2028)
Table 87. Global Health Product for Immune Revenue Forecast by Form (2023-2028) & ($ Millions)
Table 88. Global Health Product for Immune Revenue Market Share Forecast by Form (2023-2028)
Table 89. Global Health Product for Immune Sales Forecast by End Users (2023-2028) & (K Units)
Table 90. Global Health Product for Immune Sales Market Share Forecast by End Users (2023-2028)
Table 91. Global Health Product for Immune Revenue Forecast by End Users (2023-2028) & ($ Millions)
Table 92. Global Health Product for Immune Revenue Market Share Forecast by End Users (2023-2028)
Table 93. Amway Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 94. Amway Health Product for Immune Product Offered
Table 95. Amway Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Amway Main Business
Table 97. Amway Latest Developments
Table 98. Suntory Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 99. Suntory Health Product for Immune Product Offered
Table 100. Suntory Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Suntory Main Business
Table 102. Suntory Latest Developments
Table 103. GNC Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 104. GNC Health Product for Immune Product Offered
Table 105. GNC Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. GNC Main Business
Table 107. GNC Latest Developments
Table 108. INFINITUS Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 109. INFINITUS Health Product for Immune Product Offered
Table 110. INFINITUS Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. INFINITUS Main Business
Table 112. INFINITUS Latest Developments
Table 113. Herbalife Nutrition Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 114. Herbalife Nutrition Health Product for Immune Product Offered
Table 115. Herbalife Nutrition Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Herbalife Nutrition Main Business
Table 117. Herbalife Nutrition Latest Developments
Table 118. USANA Health Sciences, Inc. Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 119. USANA Health Sciences, Inc. Health Product for Immune Product Offered
Table 120. USANA Health Sciences, Inc. Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. USANA Health Sciences, Inc. Main Business
Table 122. USANA Health Sciences, Inc. Latest Developments
Table 123. PERFECT Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 124. PERFECT Health Product for Immune Product Offered
Table 125. PERFECT Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. PERFECT Main Business
Table 127. PERFECT Latest Developments
Table 128. Nestlé SA Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 129. Nestlé SA Health Product for Immune Product Offered
Table 130. Nestlé SA Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Nestlé SA Main Business
Table 132. Nestlé SA Latest Developments
Table 133. H&H Group Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 134. H&H Group Health Product for Immune Product Offered
Table 135. H&H Group Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. H&H Group Main Business
Table 137. H&H Group Latest Developments
Table 138. China New Era Group Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 139. China New Era Group Health Product for Immune Product Offered
Table 140. China New Era Group Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. China New Era Group Main Business
Table 142. China New Era Group Latest Developments
Table 143. By-health Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 144. By-health Health Product for Immune Product Offered
Table 145. By-health Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. By-health Main Business
Table 147. By-health Latest Developments
Table 148. Black Mores Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 149. Black Mores Health Product for Immune Product Offered
Table 150. Black Mores Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Black Mores Main Business
Table 152. Black Mores Latest Developments
Table 153. Glanbia Plc Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 154. Glanbia Plc Health Product for Immune Product Offered
Table 155. Glanbia Plc Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Glanbia Plc Main Business
Table 157. Glanbia Plc Latest Developments
Table 158. Nature's Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 159. Nature's Health Product for Immune Product Offered
Table 160. Nature's Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Nature's Main Business
Table 162. Nature's Latest Developments
Table 163. Real Nutriceutical Basic Information, Health Product for Immune Manufacturing Base, Sales Area and Its Competitors
Table 164. Real Nutriceutical Health Product for Immune Product Offered
Table 165. Real Nutriceutical Health Product for Immune Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Real Nutriceutical Main Business
Table 167. Real Nutriceutical Latest Developments
List of Figures
Figure 1. Picture of Health Product for Immune
Figure 2. Health Product for Immune Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Health Product for Immune Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Health Product for Immune Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Health Product for Immune Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Capsule/Pills
Figure 10. Product Picture of Powder
Figure 11. Product Picture of Liquid
Figure 12. Global Health Product for Immune Sales Market Share by Form in 2021
Figure 13. Global Health Product for Immune Revenue Market Share by Form (2017-2022)
Figure 14. Health Product for Immune Consumed in Children/Teenagers
Figure 15. Global Health Product for Immune Market: Children/Teenagers (2017-2022) & (K Units)
Figure 16. Health Product for Immune Consumed in Men
Figure 17. Global Health Product for Immune Market: Men (2017-2022) & (K Units)
Figure 18. Health Product for Immune Consumed in Adults
Figure 19. Global Health Product for Immune Market: Adults (2017-2022) & (K Units)
Figure 20. Health Product for Immune Consumed in The Elderly
Figure 21. Global Health Product for Immune Market: The Elderly (2017-2022) & (K Units)
Figure 22. Global Health Product for Immune Sales Market Share by End Users (2017-2022)
Figure 23. Global Health Product for Immune Revenue Market Share by End Users in 2021
Figure 24. Health Product for Immune Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Health Product for Immune Revenue Market Share by Company in 2021
Figure 26. Global Health Product for Immune Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Health Product for Immune Revenue Market Share by Geographic Region in 2021
Figure 28. Global Health Product for Immune Sales Market Share by Region (2017-2022)
Figure 29. Global Health Product for Immune Revenue Market Share by Country/Region in 2021
Figure 30. Americas Health Product for Immune Sales 2017-2022 (K Units)
Figure 31. Americas Health Product for Immune Revenue 2017-2022 ($ Millions)
Figure 32. APAC Health Product for Immune Sales 2017-2022 (K Units)
Figure 33. APAC Health Product for Immune Revenue 2017-2022 ($ Millions)
Figure 34. Europe Health Product for Immune Sales 2017-2022 (K Units)
Figure 35. Europe Health Product for Immune Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Health Product for Immune Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Health Product for Immune Revenue 2017-2022 ($ Millions)
Figure 38. Americas Health Product for Immune Sales Market Share by Country in 2021
Figure 39. Americas Health Product for Immune Revenue Market Share by Country in 2021
Figure 40. United States Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Health Product for Immune Sales Market Share by Region in 2021
Figure 45. APAC Health Product for Immune Revenue Market Share by Regions in 2021
Figure 46. China Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Health Product for Immune Sales Market Share by Country in 2021
Figure 53. Europe Health Product for Immune Revenue Market Share by Country in 2021
Figure 54. Germany Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Health Product for Immune Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Health Product for Immune Revenue Market Share by Country in 2021
Figure 61. Egypt Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Health Product for Immune Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Health Product for Immune in 2021
Figure 67. Manufacturing Process Analysis of Health Product for Immune
Figure 68. Industry Chain Structure of Health Product for Immune
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets